GLOBAL - Global index group FTSE has launched a new index, the FTSE techMARK mediscience, designed to reflect the market performance of growth companies listed on the London Stock Exchange's (LSE) new market, techMARK mediscience.
The new index will begin calculation today. FTSE techMARK mediscience will provide investors in small and mid-sized companies from the healthcare industry with the a measurement tool of the new medical market. The new index forms part of the FTSE techMARK Index Series, and will be reviewed quarterly, by an independent committee of market users.
Commenting on the techMARK mediscience market, Martin Wheatley, deputy CEO of LSE, said “The mediscience industry attracts a lot of interest – from issuers, investors, intermediaries and the media alike.
“By providing focus, techMARK mediscience will draw liquidity to this new market and make investment decisions easier.”
By Janet Du Chenne
HMRC has confirmed providers operating relief at source pension schemes can continue to collect automatic tax relief at a basic rate of 20% under new Scottish Income Tax rules.
The Pensions Regulator (TPR) is seeking "improved" powers to set a schedule of contributions in defined benefit (DB) schemes in the government's upcoming white paper, it has revealed.
New regulatory rules which require providers and advisers to produce annuity illustrations will not solve the problem of consumer detriment as they are "fundamentally" flawed, according to Retirement Advantage.
Paul Budgen is set to join financial technology and auto-enrolment (AE) firm Smart Pension as director of business development.